Find clinical trials for Prostate Cancer in Salt Lake City, UT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Salt Lake City, UT, USA:
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Murray, Utah, United States and 107 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Salt Lake City, Utah, United States and 9 other locations
Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 53 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Murray, Utah, United States and 52 other locations
the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...
Phase 1
Salt Lake City, Utah, United States and 15 other locations
This study evaluates the diagnostic performance and safety of \[18F\]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...
Phase 3
Salt Lake City, Utah, United States and 5 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 112 other locations
This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...
Phase 2
Salt Lake City, Utah, United States
The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatme...
Phase 2
Salt Lake City, Utah, United States
be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...
Phase 2
West Valley City, Utah, United States of America and 60 other locations
Clinical trials
Research sites
Resources
Legal